5‐5: Development of 1500PPI VR LCD display device based on LTPO process structure
SID Symposium Digest of Technical Papers · 2023-06 · 54 (1) · 47-49
DOI: 10.1002/sdtp.16484 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 30.08.2023. Verfasst von Zhen. Zhang und 11 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
In this paper, LTPO structure was used to develop 1500PPI LCD VR display device, and LTPS TFT process structure was used for peripheral driving to ensure excellent driving performance. The display area adopts oxide TFT process structure to achieve high aperture rate pixel design, and the actual aperture rate can reach 38%.In addition, the Com metal shading layer (CM) is designed above the COM electrode to block the crosstalk light of adjacent pixels and improve the crosstalk effect. The measurement is based on the perspective of 30°, Δuv
Zitieren
APA
Zhang, Z., Zhang, Z. Y., Xuan, M. H., Wang, L. Z., Tong, B. B., DI, Y. P., Han, J. H., Lin, Y. Z., Liu, D. N., Zhang, S. H., Li, P. R., & Yu, L. F. (2023). 5‐5: Development of 1500PPI VR LCD display device based on LTPO process structure. SID Symposium Digest of Technical Papers, 54(1), 47-49. https://doi.org/10.1002/sdtp.16484
Vancouver
Zhang Z, Zhang ZY, Xuan MH, Wang LZ, Tong BB, DI YP, et al. 5‐5: Development of 1500PPI VR LCD display device based on LTPO process structure. SID Symposium Digest of Technical Papers. 2023;54(1):47-49. doi:10.1002/sdtp.16484
BibTeX
@article{Zhang2023,
author = {Zhang, Zhen. and Zhang, Zhen Y. and Xuan, Ming H. and Wang, Li Z. and Tong, Bin B. and DI, Yun P. and Han, Jia H. and Lin, Yun Z. and Liu, Dong N. and Zhang, Shun H. and Li, Pei R. and Yu, Lian F.},
title = {5‐5: Development of 1500PPI VR LCD display device based on LTPO process structure},
journal = {SID Symposium Digest of Technical Papers},
year = {2023},
volume = {54},
number = {1},
pages = {47--49},
doi = {10.1002/sdtp.16484}
}
EUVIMED